VICAL INC Intellectual Property Contracts & Agreements
20 Contracts & Agreements
- License Agreements (20 contracts)
- Exclusive License Agreement, dated as of February 2, 2022, by and between Carna Biosciences, Inc. and Brickell Biotech, Inc (Filed With SEC on February 2, 2022)
- License and Development Agreement, dated as of August 27, 2021, by and between Voronoi Inc. and Brickell Biotech, Inc (Filed With SEC on September 1, 2021)
- Brickell-Kaken Amendment to Clinical Supply Agreement and License, Development and Commercialization Agreement, dated as of May 14, 2021, by and between Brickell Biotech, Inc. and... (Filed With SEC on August 12, 2021)
- Amendment to License, Development and Commercialization Agreement, dated February 24, 2016, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on June 8, 2020)
- Amended and Restated License Agreement, dated February 17, 2020, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor (Filed With SEC on February 18, 2020)
- License, Development and Commercialization Agreement, as amended, dated March 31, 2015, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on September 3, 2019)
- License Agreement, as amended, dated June 6, 2013, by and among Brickell Biotech, Inc, Orca Pharmaceuticals LLC and the New York University (Filed With SEC on September 3, 2019)
- License Agreement, dated May 20, 2011, by and between Brickell Biotech, Inc. and the University of Manchester (Filed With SEC on September 3, 2019)
- UAB Research Foundation License Agreement, as amended, dated June 26, 2012, by and between Brickell Biotech, Inc. and the UAB Research Foundation (Filed With SEC on September 3, 2019)
- License Agreement, as amended, dated December 15, 2012, by and among Brickell Biotech, Inc., Bodor Laboratories, Inc. and Nicholas S. Bodor (Filed With SEC on September 3, 2019)
- LICENSE AGREEMENT (Filed With SEC on May 8, 2015)
- 1ST AMENDMENT toEx-U.S. LICENSE AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC. (Filed With SEC on August 8, 2012)
- 1ST AMENDMENT toU.S. LICENSE AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC. (Filed With SEC on August 8, 2012)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 4, 2011)
- EX-U.S. LICENSE AGREEMENT (Filed With SEC on November 4, 2011)
- U.S. LICENSE AGREEMENT (Filed With SEC on November 4, 2011)
- Amendment to License Agreement (Filed With SEC on May 8, 2006)
- FIFTH AMENDMENT TO RESEARCHCOLLABORATION AND LICENSE AGREEMENT DATED MAY 31, 1991 (Filed With SEC on October 12, 2005)
- LICENSE AGREEMENT (Filed With SEC on August 8, 2005)
- AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on August 9, 2004)
